Company Filing History:

22 out of 6,662

Hoechst Aktiengesellschaft

patents

2 out of 330

Aventis Pharma Deutschland, Gmbh

patents

Years Active: 1989-2004

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6756489 - Substituted tetrahydropyrane derivatives, method for producing same, their use as medicine or diagnostic agent, as well as medicine containing same (2004-06-29),

2. 6399653 - Ring fused dihydropyrans, process for preparation and use thereof (2002-06-04),

3. 6245736 - Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer's disease (2001-06-12),

4. 6080719 - Cyclohexapeptides and their mixtures, a process for preparing them, and (2000-06-27),

5. 5869447 - Cyclohexapeptides and their mixtures, a process for preparing them, and (1999-02-09),

6. 5863901 - Use of bradykinin antagonists for the production of pharmaceuticals for (1999-01-26),

7. 5789383 - Bradykinin antagonists for the prophylaxis or treatment of virus diseases (1998-08-04),

8. 5672614 - Pharmaceutical use of pyridine-2,4- and -2,5-dicarboxylic acid amides (1997-09-30),

9. 5648333 - Peptides having bradykinin antagonist action (1997-07-15),

10. 5610146 - 2,3-disubstituted isoxazolidines, a process for their preparation, (1997-03-11),

11. 5597803 - Bradykinin peptides with modifications at the N terminus (1997-01-28),

12. 5512586 - Medicaments based on pyridine-2,4- and 2,5-dicarboxylic acid amides (1996-04-30),

13. 5422342 - 2,3-disubstituted isoxazolidines, agents containing them and their use (1995-06-06),

14. 5364873 - Pyridine-2,4- and dicarboxylic acid derivatives, the use thereof and (1994-11-15),

15. 5356909 - Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof (1994-10-18),

Title: Stephan Henke - A Pioneer in Pharmaceutical Innovations

Introduction

Stephan Henke, based in Bad Soden am Taunus, Germany, is a distinguished inventor renowned for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 24 patents to his name, Henke has made substantial strides in the development of innovative medicinal compounds.

Latest Patents

Among his latest advancements are patents pertaining to substituted tetrahydropyrane derivatives. These compounds have been highlighted for their efficacy as both medicinal and diagnostic agents. Additionally, he has patented methods for their production and the formulation of medicines that incorporate these innovative compounds. Another notable patent includes ring-fused dihydropyrans and the associated processes for their preparation and application, further demonstrating his expertise in the realm of chemical innovation.

Career Highlights

Henke has had an illustrious career, working with prominent companies in the pharmaceutical sector. His tenure at Hoechst Aktiengesellschaft, as well as at Aventis Pharma Deutschland GmbH, has significantly informed his innovative endeavors and patent developments. His experience in such esteemed organizations underscores his role as a thought leader in pharmaceutical research and development.

Collaborations

Throughout his career, Henke has collaborated with industry experts, including his colleagues Dietrich Brocks and Martin Bickel. These partnerships have not only enhanced his research capabilities but have also fostered an environment of innovation and intellectual exchange within his professional sphere.

Conclusion

Stephan Henke's dedication to advancing pharmaceutical science through his myriad of patents and collaborative efforts marks him as a key figure in the field. His work continues to influence medical applications, paving the way for future innovations in the industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com